Event

Journal Club - Early Phase Clinical Trials

21 July, 2011, 2 PM-3 30 PM

Add to:

Chair: Alun Bedding, Director, GlaxoSmithKline

Speaker: Timothy H Montague, GlaxoSmithKline
Sequential design approaches for bioequivalence studies with crossover designs
Co-authors: Diane Potvin, Charles E. DiLiberti, Walter W. Hauck, Alan F. Parr, Donald J. Schuirmann and Robert A. Smith
Pharmaceutical Statistics, Volume 7, Issue 4, October/December 2008, Pages: 245–262

Plus information from:
Additional results for ‘Sequential design approaches for bioequivalence studies with crossover designs’

(Subsequently published in: Pharmaceutical Statistics, Volume 11, Issue 1, pages 8–13, January/February 2012)
Abstract | Paper⁺ | Slides

Speaker: Ileana Baldi, Unit of Cancer Epidemiology, CeRMS and CPO Piemonte, University of Turin
Planning a Bayesian early-phase phase I/II study for human vaccines in HER2 carcinomas
Co-authors: Sarah Zohar, Guido Forni, Franco Merletti, Giuseppe Masucci and Dario Gregori
Pharmaceutical Statistics, Volume 10, Issue 3, pages 218–226, May/June 2011
Abstract | Paper⁺ | Slides

⁺ Papers available to view from 14^th July 2011 to 11^th August 2011.

For a flier advertising the event, please click here.

Upcoming Events

PSI EIWG Webinar: PIONEERing estimands in Clinical Research (Session 2)

19 January, 2021, 9 AM-10 30 AM

Bringing estimands to life through a real case study. Members of the estimands Implementation Working Group (EIWG) will describe the background and study objectives, intercurrent events of interest and chosen estimands in the PIONEER study.

PSI Medical Statistics Careers Event

3 March, 2021, 10 AM-5 PM

Our annual PSI Medical Statistics Careers Event, will be held online using the Career Fair Plus app on Wednesday 3rd March 2021. The event will include a live online panel discussion and a virtual exhibition session.

Associate Director, Biostatistics

Discover your extraordinary potential by working as a Covance AD, Biostatistics / Senior Principal Biostatistician. You will consult in the design of complex and innovative studies & clinical trial programs as well as Leading DMC/DSMB processes.

Director Biostatistics

By joining our company, in this role you will apply your skills and experience in support of developing scientifically based arguments aiming to provide fair accessibility to our company’s drugs and vaccines making a real difference in patient’s lives.

Senior Principal / Principal Biostatistician (Oncology) – FSP

Join our team as a Covance FSP Senior Principal or Principal Biostatistician. You will be assigned to one Sponsor working on Phase I and II oncology studies. Previous Lead experience essential. Office or home-based anywhere in Europe or South Africa.